The Lenacapavir PrEP Rollout offers six-month HIV protection, but aid cuts and clinic access gaps raise concerns for high-risk groups.
Lenacapavir PrEP Rollout Brings Hope Amid Service Cuts
Original Article by Amy Green | Spotlight | 12 May 2026
The Lenacapavir PrEP Rollout offers six-month HIV protection, but aid cuts and clinic access gaps raise concerns for high-risk groups.
More Posts
Dis-Chem succession enters a new phase
The Dis-Chem succession is pivotal as founder Ivan Saltzman resigns from formal roles. Learn about the changes happening now.
Read more...
Ectopic pregnancy deaths expose care gaps
Ectopic pregnancy deaths remain preventable in South Africa as delayed diagnosis and treatment expose gaps in district care.
Read more...
Childhood immunisation coverage falls sharply in SA
Childhood immunisation coverage is falling sharply in SA as measles and other diseases spread. See why health officials are concerned.
Read more...